Before the Bell
$
132.88
Change
-0.45 -0.34%
Volume
Volume 175
Mar 22, 2023, 4:43 a.m.
Quotes are delayed by 20 min
Previous close
$ 133.33
$ 133.33
Change
+1.25 +0.95%
Day low
Day high
$132.00
$134.77

52 week low
52 week high
$117.08
$189.07

Market cap
$31.46B
Average volume
645,964
P/E ratio
2.98
Rev. per Employee
$6.61M
EPS
44.79
Dividend
1.53
Div yield
N/A
Ex dividend date
6/2/22
MarketWatch News on BNTX
-
Moderna promises to keep COVID vaccine free
- Claudia Assis
-
Pfizer Is Moving Beyond Covid. Why Its Stock Is a Buy.
- Andrew Bary
-
Is pharma M&A making a comeback?
- Jaimy Lee
-
BioNTech to acquire AI company
- Jaimy Lee
-
BioNTech to acquire InstaDeep for 362 million pounds, pulse milestone payments of up to 200 mln more
- Ciara Linnane
-
BioNTech says deal will add about 240 skilled professionals and research partners in files of AI, machine learnings and data science
- Ciara Linnane
- Loading more headlines...
Other News on BNTX
-
Moderna CEO Defends Pricing Plans for Covid Shot
- The Wall Street Journal Interactive Edition
-
Moderna’s Earnings, Revenue Fall on Fewer Vaccine Sales
- The Wall Street Journal Interactive Edition
-
Novavax to Sell 1.5 Million More Covid Vaccines to U.S.
- The Wall Street Journal Interactive Edition
-
Pfizer Expects Drop in Revenue as Vaccine Demand Wanes
- The Wall Street Journal Interactive Edition
-
Johnson & Johnson Profit Falls 25%
- The Wall Street Journal Interactive Edition
-
A New U.S. Law Aims to Reduce Drug Prices. But First, It Might Raise Them
- The Wall Street Journal Interactive Edition
-
J&J Slashes Production of Its Covid-19 Vaccine
- The Wall Street Journal Interactive Edition
-
China Lifts Ban on Australian Coal in Move to Mend Ties
- The Wall Street Journal Interactive Edition
-
Moderna Considers Price of $110-$130 for Covid-19 Vaccine
- The Wall Street Journal Interactive Edition
-
China to Allow Rapid Tests to Confirm Covid Cases
- The Wall Street Journal Interactive Edition
-
China’s mRNA Covid Vaccine Starts Test Production
- The Wall Street Journal Interactive Edition
-
Western Covid Medicine to China’s Rescue
- The Wall Street Journal Interactive Edition
-
Boring Was King of Healthcare in 2022
- The Wall Street Journal Interactive Edition
-
Beijing’s Parcel Pileup Shows Strain of Zero-Covid Exit
- The Wall Street Journal Interactive Edition
-
Moderna’s mRNA Cancer Vaccine Shows Promise in Preliminary Study
- The Wall Street Journal Interactive Edition
-
CDC Backs New Covid Boosters for Youngest Kids
- The Wall Street Journal Interactive Edition
-
FDA Authorizes Updated Covid-19 Vaccines for Children as Young as 6 Months
- The Wall Street Journal Interactive Edition
-
New Covid-19 Booster Shots For This Fall: What to Know
- The Wall Street Journal Interactive Edition
- Loading more headlines...
Press Releases on BNTX
-
Biontech Se $BNTX Proactive Strategies
- Stock Traders Daily
-
Biontech Se $BNTX Pivots Trading Plans and Risk Controls
- Stock Traders Daily
-
Biontech Se $BNTX Investment Report
- Stock Traders Daily
-
Biontech Se (BNTX) Trading Report
- Stock Traders Daily
-
Trading Biontech Se BNTX With Integrated Risk Controls
- Stock Traders Daily
-
mRNA Vaccine and Therapeutics Market Report 2023, Size, Share, Trends and Forecast to 2028
- SUPER MARKET RESEARCH
-
Biontech Se BNTX Trading Report
- Stock Traders Daily
-
Trend Tracker for Biontech Se BNTX
- Stock Traders Daily
-
BioNTech Gains on Vaccine Deal with U.K.
- Baystreet.ca
-
- Stock Traders Daily
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com